As on Wednesday, Akari Therapeutics Plc ADR (NASDAQ: AKTX) got off with the flyer as it spiked 8.29% to $0.38, before settling in for the price of $0.35 at the close. Taking a more long-term approach, AKTX posted a 52-week range of $0.26-$1.73.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 76.60%. This publicly-traded company’s shares outstanding now amounts to $32.61 million, simultaneously with a float of $32.48 million. The organization now has a market capitalization sitting at $12.40 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6620, while the 200-day Moving Average is $1.0010.
Akari Therapeutics Plc ADR (AKTX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Akari Therapeutics Plc ADR’s current insider ownership accounts for 0.40%, in contrast to 3.62% institutional ownership. According to the most recent insider trade that took place on Aug 21 ’25, this organization’s CEO bought 10,000 shares at the rate of 0.94, making the entire transaction reach 9,400 in total value, affecting insider ownership by 287,574. Preceding that transaction, on Aug 22 ’25, Company’s CEO bought 8,000 for 0.93, making the whole transaction’s value amount to 7,440. This particular insider is now the holder of 295,574 in total.
Akari Therapeutics Plc ADR (NASDAQ: AKTX) Trading Performance Indicators
Let’s observe the current performance indicators for Akari Therapeutics Plc ADR (AKTX). It’s Quick Ratio in the last reported quarter now stands at 0.19.
In the same vein, AKTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.48, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.30 at the market close of one year from today.
Technical Analysis of Akari Therapeutics Plc ADR (AKTX)
Through scrutinizing the latest numbers posted by the [Akari Therapeutics Plc ADR, AKTX], it can be observed that its last 5-days Average volume of 1.54 million was better the volume of 0.22 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 25.24% While, its Average True Range was 37.86.
Raw Stochastic average of Akari Therapeutics Plc ADR (AKTX) in the period of the previous 100 days is set at 11.81%, which indicates a major fall in contrast to 34.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0718 that was lower than 0.0757 volatility it exhibited in the past 100-days period.
